Return to content in this issue

 

Safety and Efficacy of the First Venom Immunotherapy for Allergy to Vespa velutina nigrithorax: Interim Analysis of the W-STING Study

Carballada F1, Parra A2, Liñares T3, Giangrande N4, Varela S5, Meijide Á6, Castro M7, Tabar AI8

1Allergy Department, Hospital Universitario Lucus Augusti, Lugo, Lugo, Spain
2Allergy Department, Hospital Universitario de A Coruña, A Coruña, Spain
3Allergy Department, Complejo Hospitalario de Pontevedra, Pontevedra, Spain
4Allergy Department, Hospital Da Mariña, Burela, Lugo, Spain
5Allergy Department, Complejo Hospitalario de Ourense, Ourense, Spain
6Allergy Department, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
7Allergy Department, Complejo Hospitalario El Ferrol, Ferrol, A Coruña, Spain
8Allergy Department, Hospital Universitario de Navarra, Pamplona, Spain

J Investig Allergol Clin Immunol 2025; Vol. 35(3)
doi: 10.18176/jiaci.1058

Key words: Vespa velutina nigrithorax, Venom immunotherapy, Hymenoptera venom, Asian hornet